Sarepta Therapeutics, Inc. SRPT Acquisition Of Strategic Investments
Acquisition Of Strategic Investments at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:AcquisitionOfStrategicInvestments.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s acquisition of strategic investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s acquisition of strategic investments?
- Sarepta Therapeutics, Inc. (SRPT) reported acquisition of strategic investments of $0 in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s acquisition of strategic investments changed year-over-year?
- Sarepta Therapeutics, Inc.'s acquisition of strategic investments increased by 100.0% year-over-year, from -$241.39M to $0.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s acquisition of strategic investments?
- Over 3 years (2021 to 2024), Sarepta Therapeutics, Inc.'s acquisition of strategic investments has grown at a -100.0% compound annual growth rate (CAGR), from -$1.8M to $0.
- What does acquisition of strategic investments mean?
- Represents cash outflows for the purchase of equity interests or strategic stakes in other entities to foster long-term partnerships or technology access. This metric reflects the company's capital allocation strategy toward external innovation and collaborative growth opportunities.